000 | 01591 a2200457 4500 | ||
---|---|---|---|
005 | 20250514170024.0 | ||
264 | 0 | _c20040311 | |
008 | 200403s 0 0 eng d | ||
022 | _a0066-4804 | ||
024 | 7 |
_a10.1128/AAC.48.2.378-383.2004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMiyazaki, Shuichi | |
245 | 0 | 0 |
_aPharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models. _h[electronic resource] |
260 |
_bAntimicrobial agents and chemotherapy _cFeb 2004 |
||
300 |
_a378-83 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aArea Under Curve |
650 | 0 | 4 | _aCefepime |
650 | 0 | 4 |
_aCephalosporins _xpharmacokinetics |
650 | 0 | 4 | _aColony Count, Microbial |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aLung _xmetabolism |
650 | 0 | 4 | _aMethicillin Resistance |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred CBA |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aPneumonia, Pneumococcal _xdrug therapy |
650 | 0 | 4 |
_aSepsis _xdrug therapy |
650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aOkazaki, Kenichi | |
700 | 1 | _aTsuji, Masakatsu | |
700 | 1 | _aYamaguchi, Keizo | |
773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 2 _gp. 378-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.2.378-383.2004 _zAvailable from publisher's website |
999 |
_c14467055 _d14467055 |